EW Healthcare Partners, L.P. - 20 Oct 2023 Form 4 Insider Report for Venus Concept Inc. (VERO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Oct 2023, 16:10:07 UTC
Prior SEC filing
12 Sep 2023
Next SEC filing
19 Jan 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
EW Healthcare Partners, L.P.; By Essex Woodlands Fund IX-GP, L.P., its General Partner; By Essex Woodlands IX, LLC, its General Partner; By Scott Barry, Manager; By Gregory L. Hill, Attorney-in-Fact, /s/ Gregory L. Hill

Key filing fact

EW Healthcare Partners, L.P. filed Form 4 for Venus Concept Inc. (VERO) on 20 Oct 2023.

Key facts

  • This page summarizes EW Healthcare Partners, L.P.'s Form 4 filing for Venus Concept Inc. (VERO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 20 Oct 2023, 16:10.

Change

  • Previous filing in this sequence was filed on 12 Sep 2023.
  • Current net transaction value: +$2,000,002.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VERO transaction Derivative

Senior Convertible Preferred Stock

Purchase

Transaction value
$2,000,002
Shares
+502,513
Change %
+47%
Price
$3.98
Shares after
1,575,810
Date
20 Oct 2023
Ownership
I
Underlying class
Common Stock
Underlying amount
1,340,051
Exercise price
$0.000000
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The shares of Senior Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 2.6667 shares of Common Stock for each share of Senior Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions.

Footnote F2

The share total shown above is the aggregate amount of shares of Senior Convertible Preferred Stock purchased by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the date set forth above. EWHP purchased 483,078 shares of the amount shown above and EWHP-A purchased 19,435 shares of the amount shown above. EWHP now holds a total of 1,514,864 shares of Senior Convertible Preferred Stock (convertible into 4,039,688 shares of Common Stock) of the Issuer and EWHP-A now holds a total of 60,946 shares of Senior Convertible Preferred Stock (convertible into 162,525 shares of Common Stock) of the Issuer.

Footnote F3

Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Fund IX GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .